1. Effects of glepaglutide, a long-acting glucagon-like peptide-2 analog, on hepatic function as measured by transient elastography and indocyanine green clearance in patients with short bowel syndrome. (September 2018) Authors: Hvistendahl, M.; Naimi, R.M.; Nerup, N.A.; Ambrus, R.B.; Ring, L.L.; Achiam, M.P.; Svendsen, L.B.; Hansen, M.B.; Jeppesen, P.B. Journal: Clinical nutrition Issue: Volume 37(2018)Supplement 1 Page Start: S35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Glepaglutide, a long-acting glucagon-like peptide-2 analog, alters postprandial intestinal hormone levels but not glucose homeostasis in patients with short bowel syndrome. (September 2018) Authors: Naimi, R.M.; Hvistendahl, M.; Holst, J.J.; Hartmann, B.; Hansen, M.B.; Jeppesen, P.B. Journal: Clinical nutrition Issue: Volume 37(2018)Supplement 1 Page Start: S36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. MON-PO418: Not all Patients with Short Bowel Syndrome and Colon in Continuity have Elevated Fasting and Postprandial Responses of GLP-1 and GLP-2: A Post Hoc Analysis. (September 2019) Authors: Wangen, L.M.; Naimi, R.M.; Skaraas Johnsen, H.; Hvistendahl, M.; Jeppesen, P.B. Journal: Clinical nutrition Issue: Volume 38(2019)Supplement 1 Page Start: S213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OR023: The Glucagon-Like Peptide-1 Receptor Agonist Liraglutide Reduces Jejunostomy Output and Improves Intestinal Absorption in Short Bowel Syndrome Patients with Intestinal Failure; a Pilot Study. (September 2015) Authors: Hvistendahl, M.; Brandt, C.F.; Tribler, S.; Naimi, R.; Hartmann, B.; Holst, J.J.; Rehfeld, J.F.; Hornum, M.; Andersen, J.R.; Mortensen, P.B.; Jeppesen, P.B. Journal: Clinical nutrition Issue: Volume 34(2015)Supplement 1 Page Start: S10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SUN-PO064: Effect of Apraglutide, a Glucagon-Like Peptide-2 Analog, on Patients with Short Bowel Syndrome: Preliminary Results from an Open-Label Study. (September 2019) Authors: Eliasson, J.; Hvistendahl, M.; Naimi, R.M.; Fuglsang, K.A.; Bolognani, F.; Meyer, C.; Jeppesen, P.B. Journal: Clinical nutrition Issue: Volume 38(2019)Supplement 1 Page Start: S82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SUN-PO153: The Clinical Value of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, in Patients with Short Bowel Syndrome and Colon in Continuity: An Open-Label Pilot Study. (September 2019) Authors: Skaraas Johnsen, H.; Naimi, R.M.; Wangen, L.M.; Hvistendahl, M.; Jeppesen, P.B. Journal: Clinical nutrition Issue: Volume 38(2019)Supplement 1 Page Start: S116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗